|Free Dividend Report|
|Stock Splits Calendar|
|IBIO Stock Split History|
|Preferred Stock Newsletter|
|IBIO Options Chain|
|Stock Message Boards|
iBio (IBIO) has 1 split in our IBIO split history database. The split for IBIO took place on June 11, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of IBIO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as iBio conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the IBIO split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into iBio shares, starting with a $10,000 purchase of IBIO, presented on a split-history-adjusted basis factoring in the complete IBIO split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-30.92%|
|iBio is a developer of biopharmaceuticals and FastPharming Manufacturing System (the FastPharming System) ®. Co. applies its technologies to develop product candidates to fight fibrotic diseases, cancers, and infectious diseases. Co. uses its FastPharming Manufacturing System and Glycaneering Services to build biologic drug candidates. Co.'s segments are: Biopharmaceuticals, which includes development and licensing in therapeutics and vaccines; and Bioprocessing, which includes services (FastPharming, process development, manufacturing, as well as bioanalytical and other services) and products (growth factors, lectins, and monoclonal antibodies) for research and further manufacturing uses. According to our IBIO split history records, iBio has had 1 split.|
|IBIO Split History Table|
|06/11/2018||1 for 10|
|Healthcare Stock Splits|
|IBIO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:|